BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 29747155)

  • 1. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation and Correction of the Blood Volume Variations of Dried Blood Spots Using a Postcolumn Infused-Internal Standard Strategy with LC-Electrospray Ionization-MS.
    Liao HW; Lin SW; Chen GY; Kuo CH
    Anal Chem; 2016 Jun; 88(12):6457-64. PubMed ID: 27216241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
    Berm EJ; Brummel-Mulder E; Paardekooper J; Hak E; Wilffert B; Maring JG
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2349-53. PubMed ID: 24493333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Center punch" and "whole spot" bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS.
    Zheng N; Yuan L; Ji QC; Mangus H; Song Y; Frost C; Zeng J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():66-74. PubMed ID: 25746754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.
    Xu Y; Fang W; Zeng W; Leijen S; Woolf EJ
    Anal Bioanal Chem; 2012 Dec; 404(10):3037-48. PubMed ID: 23099526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and clinical validation of a dried blood spot assay for the determination of paclitaxel using high-performance liquid chromatography-tandem mass spectrometry.
    Andriguetti NB; Hahn RZ; Lizot LF; Raymundo S; Costa JL; da Cunha KF; Vilela RMM; Kluck HM; Schwartsmann G; Antunes MV; Linden R
    Clin Biochem; 2018 Apr; 54():123-130. PubMed ID: 29514052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
    Peeters LEJ; Feyz L; Hameli E; Zwart T; Bahmany S; Daemen J; van Gelder T; Versmissen J; Koch BCP
    Ther Drug Monit; 2020 Jun; 42(3):460-467. PubMed ID: 31593031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.
    Knapen LM; Beer Y; Brüggemann RJM; Stolk LM; Vries F; Tjan-Heijnen VCG; Erp NPV; Croes S
    J Pharm Biomed Anal; 2018 Feb; 149():106-113. PubMed ID: 29112898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
    Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of methylmalonic acid and total homocysteine analysis in dried bloodspots.
    de Sain-van der Velden MGM; van der Ham M; Jans JJ; Visser G; van Hasselt PM; Prinsen HCMT; Verhoeven-Duif NM
    Anal Chim Acta; 2015 Jan; 853():435-441. PubMed ID: 25467488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS.
    Berm EJJ; Paardekooper J; Brummel-Mulder E; Hak E; Wilffert B; Maring JG
    Talanta; 2015 Mar; 134():165-172. PubMed ID: 25618654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation.
    Martial LC; Hoogtanders KEJ; Schreuder MF; Cornelissen EA; van der Heijden J; Joore MA; Van Maarseveen EM; Burger DM; Croes S; Brüggemann RJM; Aarnoutse RE
    Ther Drug Monit; 2017 Aug; 39(4):412-421. PubMed ID: 28700522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement.
    den Burger JC; Wilhelm AJ; Chahbouni AC; Vos RM; Sinjewel A; Swart EL
    Anal Bioanal Chem; 2015 Jan; 407(2):621-7. PubMed ID: 25374126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation.
    Linder C; Hansson A; Sadek S; Gustafsson LL; Pohanka A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():116-122. PubMed ID: 29149735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of valproic acid using a dried plasma spot sampling device.
    Li Y; Jiang Y; Cao H; Lin H; Ren W; Huang J; Zhang J
    J Mass Spectrom; 2021 Apr; 56(4):e4603. PubMed ID: 33729629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DBS-LC-MS/MS assay for caffeine: validation and neonatal application.
    Bruschettini M; Barco S; Romantsik O; Risso F; Gennai I; Chinea B; Ramenghi LA; Tripodi G; Cangemi G
    Bioanalysis; 2016 Sep; 8(18):1893-902. PubMed ID: 27532249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
    Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
    Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
    Verweij-van Wissen CP; de Graaff-Teulen MJ; de Kanter CT; Aarnoutse RE; Burger DM
    Ther Drug Monit; 2015 Oct; 37(5):626-33. PubMed ID: 25627404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.
    Capiau S; Veenhof H; Koster RA; Bergqvist Y; Boettcher M; Halmingh O; Keevil BG; Koch BCP; Linden R; Pistos C; Stolk LM; Touw DJ; Stove CP; Alffenaar JC
    Ther Drug Monit; 2019 Aug; 41(4):409-430. PubMed ID: 31268966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.